Alexander finn Site

Need help? Text us, and a team member will reply in mins +1 123 456 7891
  • Manufactured in the USA
  • Batch Produced, Batch Tested
  • Fast and Discreet Shipping
  • Affordable Pricing
  • 24/7 Support
  • Manufactured in the USA

Have questions about bpc-157?
Text us: +1 123456789

Ipamorelin

Growth Compound

Price range: $69.00 through $619.00

Quantity

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is Ipamorelin?

Ipamorelin is a synthetic peptide classified as a selective ghrelin receptor agonist. In laboratory research, it is studied for its role in stimulating growth hormone (GH) release while demonstrating minimal activity on other hormones such as cortisol or prolactin.

Made in the USA

Quality controlled from start to finish.
No outsourcing.

Need Help?

Send us a message.

Contact Us

Ipamorelin Overview

Ipamorelin is a synthetic pentapeptide and selective agonist of the ghrelin receptor (GHS-R1a). It is studied in preclinical and clinical research for its ability to stimulate growth hormone release without significantly affecting cortisol or prolactin. Its selective activity makes it an important tool for investigating endocrine signaling, growth hormone regulation, and related cellular pathways.

Svensson J. et al. (1998).

History

Ipamorelin was developed in the 1990s during research into growth hormone secretagogues (GHS). Unlike earlier compounds such as GHRP-6, Ipamorelin demonstrated greater selectivity, stimulating GH release with minimal off-target hormonal effects. Since its discovery, it has been applied in studies investigating pituitary regulation, GH-dependent signaling, and metabolic pathways in laboratory models.

Bowers C.Y. et al. (1997).

Ipamorelin Structure

CAS #: 170851-70-4

Molecular Formula: C₃₈H₄₉N₉O₅

Molecular Weight: 711.9 g/mol

PubChem ID: 9831659

Research Findings

Ipamorelin has been studied in endocrine, metabolic, and regenerative models, with research highlighting its activity in stimulating growth hormone release, modulating IGF-1 pathways, and supporting tissue recovery processes. Studies have also examined its role in metabolic regulation, energy balance, and cellular repair in preclinical systems.

Key Areas of Research:

• Endocrine: GH release, IGF-1 signaling, pathways

• Metabolic: energy balance, glucose regulation

• Cellular: repair, proliferation, recovery

Together, these findings suggest experimental utility for Ipamorelin across multiple biological pathways. By influencing growth hormone secretion and downstream metabolic and regenerative processes, Ipamorelin provides a versatile platform for research into tissue recovery, endocrine activity, and systemic resilience in laboratory models.

Raun K. et al., 1998

References

Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release in humans without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094–3101. 

Bowers C.Y. et al. (1997). Ipamorelin: a novel pentapeptide GH secretagogue. Endocrinology, 138(9): 4011–4016. 

Culler M.D. et al. (2002). Pharmacological characterization of Ipamorelin, a GHRP with GH selectivity. J Endocrinol, 174(2):R1–R6. 

Description

Ipamorelin Overview

Ipamorelin is a synthetic pentapeptide and selective agonist of the ghrelin receptor (GHS-R1a). It is studied in preclinical and clinical research for its ability to stimulate growth hormone release without significantly affecting cortisol or prolactin. Its selective activity makes it an important tool for investigating endocrine signaling, growth hormone regulation, and related cellular pathways.

Svensson J. et al. (1998).

History

Ipamorelin was developed in the 1990s during research into growth hormone secretagogues (GHS). Unlike earlier compounds such as GHRP-6, Ipamorelin demonstrated greater selectivity, stimulating GH release with minimal off-target hormonal effects. Since its discovery, it has been applied in studies investigating pituitary regulation, GH-dependent signaling, and metabolic pathways in laboratory models.

Bowers C.Y. et al. (1997).

Ipamorelin Structure

CAS #: 170851-70-4

Molecular Formula: C₃₈H₄₉N₉O₅

Molecular Weight: 711.9 g/mol

PubChem ID: 9831659

Research Findings

Ipamorelin has been studied in endocrine, metabolic, and regenerative models, with research highlighting its activity in stimulating growth hormone release, modulating IGF-1 pathways, and supporting tissue recovery processes. Studies have also examined its role in metabolic regulation, energy balance, and cellular repair in preclinical systems.

Key Areas of Research:

• Endocrine: GH release, IGF-1 signaling, pathways

• Metabolic: energy balance, glucose regulation

• Cellular: repair, proliferation, recovery

Together, these findings suggest experimental utility for Ipamorelin across multiple biological pathways. By influencing growth hormone secretion and downstream metabolic and regenerative processes, Ipamorelin provides a versatile platform for research into tissue recovery, endocrine activity, and systemic resilience in laboratory models.

Raun K. et al., 1998

References

Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release in humans without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094–3101. 

Bowers C.Y. et al. (1997). Ipamorelin: a novel pentapeptide GH secretagogue. Endocrinology, 138(9): 4011–4016. 

Culler M.D. et al. (2002). Pharmacological characterization of Ipamorelin, a GHRP with GH selectivity. J Endocrinol, 174(2):R1–R6. 

Additional information

Pcs

Pack of 10, Single Vial
Strength

10mg, 5mg

Reviews

There are no reviews yet.

Be the first to review “Ipamorelin”

Your email address will not be published. Required fields are marked *

Text us, our dedicated team is here to help.

Reach out and get a response within minutes

+1 123456789

Text Us